Market Indices


Latest News

from Wedbush issued a price target of $11.00 for

May 8, 2026   STTK 9.42%

from Wedbush issued a price target of $166.00 for

May 8, 2026   PRAX -0.98%

from Lake Street issued a price target of $36.00 for...

May 8, 2026   BKSY 22.36%

from Deutsche Bank issued a price target of $420.00 for...

May 8, 2026   PRAX -0.98%

from Deutsche Bank issued a price target of $35.00 for...

May 8, 2026   BKSY 22.36%


Price Targets

from Wedbush issued a price target of $11.00 for STTK on 2026-05-08 13:39:10.The adjusted price target was set to $11.00.At the time of the announcement, STTK was...

May 8, 2026   STTK 9.42%

from Wedbush issued a price target of $166.00 for PRAX on 2026-05-08 13:37:03.The adjusted price target was set to $166.00.At the time of the announcement, PRAX was...

May 8, 2026   PRAX -0.98%

from Lake Street issued a price target of $36.00 for BKSY on 2026-05-08 12:55:32.The adjusted price target was set to $36.00.At the time of the announcement, BKSY...

May 8, 2026   BKSY 22.36%

from Deutsche Bank issued a price target of $420.00 for PRAX on 2026-05-08 12:53:54.The adjusted price target was set to $420.00.At the time of the announcement, PRAX...

May 8, 2026   PRAX -0.98%

from Deutsche Bank issued a price target of $35.00 for BKSY on 2026-05-08 12:48:44.The adjusted price target was set to $35.00.At the time of the announcement, BKSY...

May 8, 2026   BKSY 22.36%



Market Movers

Top Gainers (%)
NKGN
NKGen Biotech, Inc. Commo
0.16
166.67%
INOD
Innodata Inc.
84.89
86.00%
WGSWW
WGSWW
0.01
71.88%
DRTSW
Alpha Tau Medical Ltd. Wa
1.32
34.18%
ARAY
Accuray Incorporated
0.38
29.65%
EOSE
Eos Energy Enterprises, I
8.01
25.94%
MRAM
Everspin Technologies, In
26.99
25.48%
ZTEK
Zentek Ltd.
0.75
25.13%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP 7.09%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE 25.94%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK 0.30%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN -0.43%